Medtronic plc [MDT] Revenue clocked in at $30.77 billion, up 5.06% YTD: What’s Next?

Medtronic plc [NYSE: MDT] slipped around -0.47 points on Tuesday, while shares priced at $81.65 at the close of the session, down -0.57%. The company report on April 12, 2023 that Building Stronger Businesses – Together.

Tiny parts like precision mechanical springs and wire forms bring many of the innovative devices at Medtronic to life. And we care about where they come from – both from a quality and a community standpoint.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


For us, Springfield Spring and Stamping, a certified minority-owned company, delivers both. And obtaining corporate clients like Medtronic was key to the Massachusetts-based company’s growth.

Medtronic plc stock is now 5.06% up from its year-to-date (YTD) trading value. MDT Stock saw the intraday high of $82.75 and lowest of $81.595 per share. The company’s 52-week high price is 114.31, which means current price is +7.41% above from all time high which was touched on 02/02/23.

Compared to the average trading volume of 5.87M shares, MDT reached a trading volume of 4156586 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Medtronic plc [MDT]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $88.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

UBS have made an estimate for Medtronic plc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on March 29, 2023. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $102 to $89. The new note on the price target was released on January 09, 2023, representing the official price target for Medtronic plc stock. Previously, the target price had yet another drop from $106 to $85, while Oppenheimer kept a Perform rating on MDT stock. On November 23, 2022, analysts decreased their price target for MDT shares from 108 to 85.

The Average True Range (ATR) for Medtronic plc is set at 1.44, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 3.57. The Price to Book ratio for the last quarter was 2.11, with the Price to Cash per share for the same quarter was set at 8.28. Price to Free Cash Flow for MDT in the course of the last twelve months was 179.14 with Quick ratio for the last quarter at 1.40.

How has MDT stock performed recently?

Medtronic plc [MDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.80. With this latest performance, MDT shares gained by 4.29% in over the last four-week period, additionally plugging by 0.05% over the last 6 months – not to mention a drop of -25.11% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 55.44, with the RSI for the last a single of trading hit 58.80, and the three-weeks RSI is set at 53.21 for Medtronic plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 81.37, while it was recorded at 81.38 for the last single week of trading, and 83.99 for the last 200 days.

Medtronic plc [MDT]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Medtronic plc [MDT] shares currently have an operating margin of +19.53 and a Gross Margin at +62.88. Medtronic plc’s Net Margin is presently recorded at +15.91.

Return on Total Capital for MDT is now 7.90, given the latest momentum, and Return on Invested Capital for the company is 6.62. Return on Equity for this stock inclined to 9.69, with Return on Assets sitting at 5.48. When it comes to the capital structure of this company, Medtronic plc [MDT] has a Total Debt to Total Equity ratio set at 47.54. Additionally, MDT Total Debt to Total Capital is recorded at 32.22, with Total Debt to Total Assets ending up at 27.46. Long-Term Debt to Equity for the company is recorded at 40.10, with the Long-Term Debt to Total Capital now at 27.18.

Reflecting on the efficiency of the workforce at the company, Medtronic plc [MDT] managed to generate an average of $53,053 per employee. Receivables Turnover for the company is 5.75 with a Total Asset Turnover recorded at a value of 0.34.Medtronic plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.80.

Earnings analysis for Medtronic plc [MDT]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic plc go to 2.14%.

Insider trade positions for Medtronic plc [MDT]

There are presently around $89,133 million, or 84.60% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 125,126,702, which is approximately 1.021% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 122,290,951 shares of the stock with an approximate value of $10.04 billion in MDT stocks shares; and STATE STREET CORP, currently with $4.93 billion in MDT stock with ownership of nearly 1.762% of the company’s market capitalization.

Positions in Medtronic plc stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 953 institutional holders increased their position in Medtronic plc [NYSE:MDT] by around 63,331,647 shares. Additionally, 1,000 investors decreased positions by around 61,754,920 shares, while 166 investors held positions by with 960,312,116 shares. The mentioned changes placed institutional holdings at 1,085,398,683 shares, according to the latest SEC report filing. MDT stock had 195 new institutional investments in for a total of 6,684,073 shares, while 154 institutional investors sold positions of 8,078,466 shares during the same period.


Please enter your comment!
Please enter your name here